Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(7%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
10
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
N/ANon-phased studies
10(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)
Other(4)

Detailed Status

Completed7
unknown4
Not yet recruiting2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
87.5%
Most Advanced
N/A

Trials by Phase

N/A10 (100.0%)

Trials by Status

completed747%
not_yet_recruiting213%
unknown427%
recruiting17%
terminated17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07365111

Insights Into the Continuous Renal Replacement Therapy to Critical Ill Patients

Not Yet Recruiting
NCT05989971

The Effect of Continuous Renal Replacement Therapy on the Efficiency of Extracorporeal CO2 Removal

Completed
NCT05209230Not Applicable

Is Myocardial Stunning Induced by Continuous Renal Replacement Therapy a Reality in Critically Ill Patients?

Completed
NCT06901011Not Applicable

Continuous Renal Replacement Therapy Doses in Critically Ill Patients With Acute Kidney Injury

Not Yet Recruiting
NCT06844435Not Applicable

Continuous Renal Replacement Therapy (CRRT) in Surgery Room During Orthotopic Liver Transplantation (OLT)

Completed
NCT06226441Not Applicable

Aminoglycoside Administration in Septic Patients

Recruiting
NCT04494542Not Applicable

Sustained Low Efficiency Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury in Critically Ill Cirrhotics

Completed
NCT05349305

Population Pharmacokinetics of Lassila Tazobactam in Patients After Aortic Dissection

Unknown
NCT04306705

Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19

Unknown
NCT02963298Not Applicable

CRRT for Glutamate Elimination After Cardiac Arrest

Completed
NCT01416298Not Applicable

Use of Biomarkers to Optimize Fluid Dosing,CRRT Initiation and Discontinuation in Pediatric ICU Patients With AKI

Terminated
NCT01819038Not Applicable

Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury

Completed
NCT02034448

CRRTNet Registry- A Prospective Observational Registry

Unknown
NCT01501097Not Applicable

The Impact of Continuous Renal Replacement Therapy on the Outcomes of Burn Patients With Early Phase of Sepsis

Unknown
NCT00537693Not Applicable

Cytokine Removal by CRRT in Pediatric Sepsis

Completed

All 15 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
15